20374-33-8Relevant articles and documents
PANTETHENOYLCYSTEINE DERIVATIVES AND USES THEREOF
-
Paragraph 3270, (2020/10/20)
The present disclosure relates to compounds of Formula (I) or (II): (Formulae (I), (II)), and pharmaceutically acceptable salts or solvates thereof. The present disclosure also relates to pharmaceutical compositions comprising the compounds and therapeutic and diagnostic uses of the compounds and pharmaceutical compositions.
Enantiodivergent syntheses of pantolactone and pantothenic acid from d -mannitol
Sanyal, Ishita,Barman, Piyalideb,Banerjee, Asishkumar
, p. 1102 - 1108 (2012/05/04)
Efficient synthetic routes to both the enantiomers of pantolactone and pantothenic acid have been developed starting from d-mannitol-based d-glyceraldehyde acetonide through its conversion into a protected pantoic acid intermediate followed by either cyclization or amide bond formation with a -amino ester, and subsequent appropriate deprotection. Georg Thieme Verlag Stuttgart . New York.
Synthesis of molluscicidal agent cyanolide a macrolactone from D-(-)-Pantolactone
Hajare, Atul K.,Ravikumar, Velayutham,Khaleel, Shaik,Bhuniya, Debnath,Reddy, D. Srinivasa
supporting information; experimental part, p. 963 - 966 (2011/04/18)
An efficient synthesis of potent molluscicidal agent cyanolide A, a glycosidic 16-membered macrolide, starting from D-(-)-pantolactone is reported. Highly stereoselective aldol, oxa-Michael addition, and Yamaguchi macrolactonization are the key steps in the present synthesis.